A pilot study evaluating the role of ivabradine for rate control in patients with rheumatic atrial fibrillation

CONCLUSION: Our data suggest that Ivabradine can be an option for rate control in rheumatic AF.PMID:37666416 | DOI:10.1016/j.ihj.2023.08.006

Source: Indian Heart J - September 4, 2023 Category: Cardiology Authors: Arpita Katheria Aditya Kapoor Ankit Sahu Kamlesh Raut Harshit Khare Roopali Khanna Sudeep Kumar Naveen Garg Satyendra Tewari Source Type: research